Skip to main content
. 2017 Sep 11;17(4):585–596. doi: 10.1007/s40268-017-0209-5

Fig. 4.

Fig. 4

Kaplan–Meier curves. Overall progression-free survival (PFS), from starting the sunitinib 4/2 schedule (a); PFS according to Heng score (blue line good risk; green line intermediate risk: orange line poor risk) (b); and overall survival (c)